Patrick Schauerte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Patrick Schauerte has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
Karl Mischke
8 shared publications- Karl Mischke
Department of Cardiology, RWTH Aachen University, 52074 Aachen, Germany
8 shared publications Jurgita Plisiene
Cardiothoracic Surgery, Technical University Aachen, Aachen, Germany
6 shared publicationsChristian Knackstedt
Department of Cardiology , RWTH Aachen University , Pauwelsstrasse 30, 52074 Aachen , Germany
5 shared publications- Malte Kelm
Department of Cardiology, Pneumology and Angiology, University Hospital Düsseldorf, Düsseldorf, Germany
5 shared publications Markus Zarse
Department of Cardiology , RWTH Aachen University , Pauwelsstrasse 30, 52074 Aachen , Germany
5 shared publications
Latest Publications
- 1 July 2013
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 96 (1) , 293-296
Video-Assisted Pericardioscopic Surgery for Epimyocardial Lead Implantation
- 1 July 2013
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 96 (1) , 293-296
Video-Assisted Pericardioscopic Surgery for Epimyocardial Lead Implantation
- 1 January 2013
- Published by EJournal Publishing in Journal of Life Sciences and Technologies
- p. 223-227
Heart Cycle Length Modulation by Electrical Neurostimulation in the High Right Human Atrium
- 1 January 2013
- Published by EJournal Publishing in Journal of Life Sciences and Technologies
- p. 223-227
Heart Cycle Length Modulation by Electrical Neurostimulation in the High Right Human Atrium
- 1 January 2012
- Published by Elsevier in Cellular Signalling
- Vol. 24 (1) , 99-105
Rate and irregularity of electrical activation during atrial fibrillation affect myocardial NGF expression via different signalling routes
- 1 January 2012
- Published by Elsevier in Cellular Signalling
- Vol. 24 (1) , 99-105
Rate and irregularity of electrical activation during atrial fibrillation affect myocardial NGF expression via different signalling routes
- 19 November 2011
- Published by Springer Nature in Herz
- Vol. 37 (5) , 518-526
A dedicated cardioversion unit for the treatment of atrial fibrillation
- 19 November 2011
- Published by Springer Nature in Herz
- Vol. 37 (5) , 518-526
A dedicated cardioversion unit for the treatment of atrial fibrillation
- 30 September 2011
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 413 (3) , 432-435
Irregular electrical activation of intrinsic cardiac adrenergic cells increases catecholamine-synthesizing enzymes
- 30 September 2011
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 413 (3) , 432-435
Irregular electrical activation of intrinsic cardiac adrenergic cells increases catecholamine-synthesizing enzymes
- 1 January 2011
- No. 2,p. 175-180
Electrical remodelling in cardiac resynchronization therapy: decrease in intrinsic QRS duration
- 1 January 2011
- No. 2,p. 175-180
Electrical remodelling in cardiac resynchronization therapy: decrease in intrinsic QRS duration
- 30 April 2010
- Published by Peeters Publishers in Acta Cardiologica
- Vol. 65 (2) , 161-170
Registration of coronary venous anatomy to the site of the latest mechanical contraction
Cardiac resynchronization therapy (CRT) provides a therapeutic option for patients with congestive heart failure (CHF). There is evidence that the optimal pacing site (OIS) is vicinal to the region of the latest contraction (RLC). However, the RLC is not identified routinely to guide lead implantation to the coronary venous system (CVS). The aim of this study was: (i) to develop a software over-imposing CVS-anatomy on parametric images of left ventricular dyssynchrony in a 3D-format obtained from computed tomography (CT) and cardiac magnetic resonance imaging (MRI); and (ii) to apply this 3D-software for analysing the possible correlation between functional/ clinical improvement and the distance between final implantation site (FIS) and RLC. In 20 CHF-patients (11 men, 65.6 +/- 6.8 y, ejection fraction (EF): 27.5 +/- 6.1%) CRT-leads were implanted; follow-up included echocardiographic and exercise evaluation. The OIS and the FIS were noted on 3D-registrations and the distances OIS-RLC and FIS-RLC measured.The target vessel was reached in 14 cases. NYHA class and EF improved significantly with a low rate of non-responders of 3 (15%) (EF) and 4 (20%) (NYHA). Image registration was possible in all patients. Post-process 3D-analysis revealed no correlation between the distance FIS-RLC and functional or echocardiographic improvements.There was a trend towards a shorter distance FIS-RLC in patients classified as responders (EF). NYHA class improved significantly better in patients with target vessel implantation. Registration of CT/MRI-images enables efforts to reach the RLC by preoperative identification of corresponding veins. Larger randomized trials must define the definite therapeutic benefit.
- 30 April 2010
- Published by Peeters Publishers in Acta Cardiologica
- Vol. 65 (2) , 161-170
Registration of coronary venous anatomy to the site of the latest mechanical contraction
Cardiac resynchronization therapy (CRT) provides a therapeutic option for patients with congestive heart failure (CHF). There is evidence that the optimal pacing site (OIS) is vicinal to the region of the latest contraction (RLC). However, the RLC is not identified routinely to guide lead implantation to the coronary venous system (CVS). The aim of this study was: (i) to develop a software over-imposing CVS-anatomy on parametric images of left ventricular dyssynchrony in a 3D-format obtained from computed tomography (CT) and cardiac magnetic resonance imaging (MRI); and (ii) to apply this 3D-software for analysing the possible correlation between functional/ clinical improvement and the distance between final implantation site (FIS) and RLC. In 20 CHF-patients (11 men, 65.6 +/- 6.8 y, ejection fraction (EF): 27.5 +/- 6.1%) CRT-leads were implanted; follow-up included echocardiographic and exercise evaluation. The OIS and the FIS were noted on 3D-registrations and the distances OIS-RLC and FIS-RLC measured.The target vessel was reached in 14 cases. NYHA class and EF improved significantly with a low rate of non-responders of 3 (15%) (EF) and 4 (20%) (NYHA). Image registration was possible in all patients. Post-process 3D-analysis revealed no correlation between the distance FIS-RLC and functional or echocardiographic improvements.There was a trend towards a shorter distance FIS-RLC in patients classified as responders (EF). NYHA class improved significantly better in patients with target vessel implantation. Registration of CT/MRI-images enables efforts to reach the RLC by preoperative identification of corresponding veins. Larger randomized trials must define the definite therapeutic benefit.
- 26 January 2010
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 21 (2) , 193-199
Chronic Augmentation of the Parasympathetic Tone to the Atrioventricular Node: A Nonthoracotomy Neurostimulation Technique for Ventricular Rate Control During Atrial Fibrillation
Long‐Term Cardiac Neurostimulation. Introduction: The right inferior ganglionated plexus (RIGP) selectively innervates the atrioventricular node. Temporary electrical stimulation of this plexus reduces the ventricular rate during atrial fibrillation (AF). We sought to assess the feasibility of chronic parasympathetic stimulation for ventricular rate control during AF with a nonthoracotomy intracardiac neurostimulation approach. Methods and Results: In 9 mongrel dogs, the small endocardial area inside the right atrium, which overlies the RIGP, was identified by 20 Hz stimulation over a guiding catheter with integrated electrodes. Once identified, an active‐fixation lead was implanted. The lead was connected to a subcutaneous neurostimulator. An additional dual‐chamber pacemaker was implanted for AF induction by rapid atrial pacing and ventricular rate monitoring. Continuous neurostimulation was delivered for 1–2 years to decrease the ventricular rate during AF to a range of 100–140 bpm. Implantation of a neurostimulation lead was achieved within 37 ± 12 min. The latency of the negative dromotropic response after on/offset or modulation of neurostimulation was Conclusion: Chronic parasympathetic stimulation can be achieved via a cardiac neurostimulator. The approach is safe, effective, and well tolerated in the long term. The atrioventricular nodal selectivity and the opportunity to adjust the negative dromotropic effect within seconds may represent an advantage over pharmacological rate control. (J Cardiovasc Electrophysiol, Vol. 21, pp. 193‐199, February 2010)
- 26 January 2010
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 21 (2) , 193-199
Chronic Augmentation of the Parasympathetic Tone to the Atrioventricular Node: A Nonthoracotomy Neurostimulation Technique for Ventricular Rate Control During Atrial Fibrillation
Long‐Term Cardiac Neurostimulation. Introduction: The right inferior ganglionated plexus (RIGP) selectively innervates the atrioventricular node. Temporary electrical stimulation of this plexus reduces the ventricular rate during atrial fibrillation (AF). We sought to assess the feasibility of chronic parasympathetic stimulation for ventricular rate control during AF with a nonthoracotomy intracardiac neurostimulation approach. Methods and Results: In 9 mongrel dogs, the small endocardial area inside the right atrium, which overlies the RIGP, was identified by 20 Hz stimulation over a guiding catheter with integrated electrodes. Once identified, an active‐fixation lead was implanted. The lead was connected to a subcutaneous neurostimulator. An additional dual‐chamber pacemaker was implanted for AF induction by rapid atrial pacing and ventricular rate monitoring. Continuous neurostimulation was delivered for 1–2 years to decrease the ventricular rate during AF to a range of 100–140 bpm. Implantation of a neurostimulation lead was achieved within 37 ± 12 min. The latency of the negative dromotropic response after on/offset or modulation of neurostimulation was Conclusion: Chronic parasympathetic stimulation can be achieved via a cardiac neurostimulator. The approach is safe, effective, and well tolerated in the long term. The atrioventricular nodal selectivity and the opportunity to adjust the negative dromotropic effect within seconds may represent an advantage over pharmacological rate control. (J Cardiovasc Electrophysiol, Vol. 21, pp. 193‐199, February 2010)
- Open Access
- 26 June 2009
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 11 (8) , 1090-1096
Targeting of cardiac autonomic plexus for modulation of intracardiac neural tone
Ventricular rate control is considered as an initial choice of therapy in many patients with atrial fibrillation (AF). We could previously show that electrostimulation of the right inferior ganglionated plexus (RIGP), which supplies the AV node, instantly decreases ventricular rate during AF. This study describes the development of a technique to reliably implant a chronic lead inside the RIGP. In nine mongrel dogs with AF, the RIGP was identified by neuromapping with probatory high-frequency stimulation (20 Hz) over steerable electrode catheters until a significant ventricular rate slowing was achieved. Then an active fixation, permanent pacemaker lead was fixed closed to the mapping catheter left in place as anatomical marker. Initially ( n = 4) available guiding catheters and steerable lead stylets were employed to navigate and anchor the lead, which resulted in repetitive screw-in attempts. Therefore, a guiding catheter was developed, which allowed angiography, lead advancement through its lumen, and probatory neurostimulation over its tip. This tool allowed lead delivery within 40 min ( n = 5). Neurostimulation via the permanent lead elicited negative dromotropic effects with stimulation frequency, voltage, and impulse duration as determinants of stimulation efficacy. Active fixation of a permanent pacing lead inside the RIGP is feasible without thoracotomy. Thereby, ventricular rate control during AF can be achieved with stimulus voltages applied for myocardial electrostimulation.
- 26 June 2009
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 11 (8) , 1090-1096
Open AccessTargeting of cardiac autonomic plexus for modulation of intracardiac neural tone
Ventricular rate control is considered as an initial choice of therapy in many patients with atrial fibrillation (AF). We could previously show that electrostimulation of the right inferior ganglionated plexus (RIGP), which supplies the AV node, instantly decreases ventricular rate during AF. This study describes the development of a technique to reliably implant a chronic lead inside the RIGP. In nine mongrel dogs with AF, the RIGP was identified by neuromapping with probatory high-frequency stimulation (20 Hz) over steerable electrode catheters until a significant ventricular rate slowing was achieved. Then an active fixation, permanent pacemaker lead was fixed closed to the mapping catheter left in place as anatomical marker. Initially ( n = 4) available guiding catheters and steerable lead stylets were employed to navigate and anchor the lead, which resulted in repetitive screw-in attempts. Therefore, a guiding catheter was developed, which allowed angiography, lead advancement through its lumen, and probatory neurostimulation over its tip. This tool allowed lead delivery within 40 min ( n = 5). Neurostimulation via the permanent lead elicited negative dromotropic effects with stimulation frequency, voltage, and impulse duration as determinants of stimulation efficacy. Active fixation of a permanent pacing lead inside the RIGP is feasible without thoracotomy. Thereby, ventricular rate control during AF can be achieved with stimulus voltages applied for myocardial electrostimulation.